Dyadic International Inc. (DYAI) vs Palatin Technologies, Inc. (PTN)

Dyadic International Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Dyadic International Inc. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.4M). Dyadic International Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 86.5% against −8.05%. Palatin Technologies, Inc. has the higher net margin (−47.2% vs −200.5%) and the lower return on invested capital (−942.3% vs 0.00%). Across the 17 metrics below, Palatin Technologies, Inc. leads on 13 and Dyadic International Inc. on 4.

Valuation

Metric DYAI PTN Biotechnology median
P/E n/m 2.43 7.88
P/S 4.03 2.99 11.47
P/B n/m 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.12 2.23 10.73
Earnings yield (54.76%) 41.20% (28.84%)
Free cash flow yield (49.10%) (37.93%) (23.03%)

Profitability

Metric DYAI PTN Biotechnology median
Gross margin 16.24% 100.00% 65.16%
Operating margin (195.47%) (49.26%) 0.00%
Net margin (200.46%) (47.22%) 0.00%
Free cash flow margin (194.73%) (113.25%) 0.00%
Return on equity 522.58% (297.25%) (57.72%)
Return on assets (103.88%) (73.72%) (49.22%)
Return on invested capital 0.00% (942.30%) 0.00%

Growth

Metric DYAI PTN Biotechnology median
Revenue growth (TTM) (8.05%) 86.46% 5.64%
EPS growth (last fiscal year) (15.00%) 68.15% —
Revenue growth, 5-year CAGR 14.04% (40.52%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYAI PTN Biotechnology median
Debt to equity (2.11) 0.00 0.00
Current ratio 1.65 5.04 4.73
Net debt to EBITDA 0.49 0.15 0.96

Dividend

Metric DYAI PTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DYAI PTN Biotechnology median
Market cap 17.44m 17.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack